Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products

This publication has 13 references indexed in Scilit:

• Evaluating the Feasibility of Electronic Health Records and Claims Data Sources for Specific Research Purposes
  Therapeutic Innovation & Regulatory Science, 2020
• Transparent Reporting on Research Using Unstructured Electronic Health Record Data to Generate ‘Real World’ Evidence of Comparative Effectiveness and Safety
  Drug Safety, 2019
• A Structured Preapproval and Postapproval Comparative Study Design Framework to Generate Valid and Transparent Real‐World Evidence for Regulatory Decisions
  Clinical Pharmacology & Therapeutics, 2019
• Considerations in characterizing real‐world data relevance and quality for regulatory purposes: A commentary
  Pharmacoepidemiology and Drug Safety, 2018
• Risk based monitoring (RBM) tools for clinical trials: A systematic review
  Contemporary Clinical Trials, 2016
• Pharmacogenetics of Opioid Response
  Clinical Pharmacology & Therapeutics, 2014
• Misclassification in Administrative Claims Data: Quantifying the Impact on Treatment Effect Estimates
  Current Epidemiology Reports, 2014
• Pre-study feasibility and identifying sensitivity analyses for protocol pre-specification in comparative effectiveness research
  Journal of Comparative Effectiveness Research, 2014
• Guidelines for good database selection and use in pharmacoepidemiology research
  Pharmacoepidemiology and Drug Safety, 2011
• Applying Quantitative Bias Analysis to Epidemiologic Data
  2009